[1]
D.-V. Dulf, “Real-world benchmarks for metastatic urothelial carcinoma: a single-center analysis of two standard immunotherapy pathways in Romania”, Med Pharm Rep, vol. 99, no. 2, pp. 120–128, Mar. 2026.